SpyGlass Pharma is pursuing a $100 million IPO to advance its glaucoma drug delivery platform through Phase 3 trials. Read ...

Five diagnostic tools are critical to assist surgeons in choosing the most appropriate IOL for the patient and maintaining ...

Henderson, NV - January 16, 2026 - PRESSADVANTAGE - Las Vegas Eye Institute announces the integration of Ray-Traced ...

OMAHA, NE - January 08, 2026 - PRESSADVANTAGE - Kugler Vision announced the publication of its new feature, “Dr. Lance ...

AI has the potential to transform cataract surgery outcomes for the better, according to a speaker. Surgical planning, predictive analytics for patient recovery and postoperative assessments are a few ...

An activist investor has reshaped the board, securing the departures of STAAR’s CEO and chair.

India’s eye care landscape is witnessing a significant paradigm shift driven by precision innovations in cataract surgery and the advent of specialized defocus lenses for myopia management. Advanced ...

Staar Surgical CEO Stephen Farrell and Board of Directors Chair Elizabeth Yeu have stepped down from the company’s board, effective immediately.

From artificial intelligence and IOL innovation to biosimilars, geographic atrophy, and postoperative eye protection, Joshua ...

After the termination of the proposed acquisition by Alcon, STAAR has announced changes to its board of directors in a cooperation agreement with Broadwood Partners. 1 ...